Publications by authors named "Kalkowski L"

Article Synopsis
  • Current radiotherapy treatments for glioblastoma (GBM) are often ineffective, but regenerative medicine offers new possibilities for increasing radiation doses safely.
  • The study investigated the effects of ultra-high dose fractionated radiation on tumors and brain injury in immunocompetent mice, assessing how the hypoxia-inducible factor-1 alpha (Hif-1α) might help reduce radiation-induced damage.
  • Results showed that a fractionated radiation regimen of 3×20 Gy eradicated GBM with mild brain injury, while higher doses caused severe damage; targeting Hif-1α may help mitigate vascular issues following radiation.
View Article and Find Full Text PDF
Article Synopsis
  • Conventional radiation therapy for glioblastoma (GBM) has limitations, but this study investigates the effects of ultra-high dose fractionated radiation on brain injury and tumor responses in mice while assessing the role of the HIF-1α protein.
  • The research involved different groups of mice receiving varying doses of radiation, with assessments done using MRI and other techniques to monitor brain damage and tumor growth.
  • Results showed that a dose of 3×20 Gy effectively eradicated GBM with only mild brain injury, suggesting that targeting HIF-1α could help reduce vascular damage following radiation, paving the way for improved treatments.
View Article and Find Full Text PDF
Article Synopsis
  • Multiple sclerosis is a long-term brain and spinal cord disease that causes damage to nerve fibers, and while current treatments can slow progression, they don't cure it.
  • Most patients respond positively to current therapies, but some experience rapid disease progression, and standard drug delivery methods often struggle to effectively target the central nervous system.
  • Exploring alternative drug delivery methods that enhance drug accumulation in the brain could improve outcomes for those patients, potentially reducing side effects despite requiring more invasive methods.
View Article and Find Full Text PDF

Development of a novel, animal model for multiple sclerosis (MS) with reproducible and predictable lesion placement would enhance the discovery of effective treatments. Therefore, we would like to combine the advantages of the demyelination model with experimental autoimmune encephalomyelitis (EAE) to provide a local autoimmune encephalomyelitis (LAE) inside rat brain. We induced a demyelinating lesion by immunizing male Wistar rats, followed by blood-brain barrier opening protein (vascular endothelial growth factor) by stereotactic injection.

View Article and Find Full Text PDF

Cell therapy is a promising tool for treating central nervous system (CNS) disorders; though, the translational efforts are plagued by ineffective delivery methods. Due to the large contact surface with CNS and relatively easy access, the intrathecal route of administration is attractive in extensive or global diseases such as stroke or amyotrophic lateral sclerosis (ALS). However, the precision and efficacy of this approach are still a challenge.

View Article and Find Full Text PDF

Stem cell transplantation proved promising in animal models of neurological diseases; however, in conditions with disseminated pathology such as ALS, delivery of cells and their broad distribution is challenging. To address this problem, we explored intra-arterial (IA) delivery route, of stem cells. The goal of this study was to investigate the feasibility and safety of MRI-guided transplantation of glial restricted precursors (GRPs) and mesenchymal stem cells (MSCs) in dogs suffering from ALS-like disease, degenerative myelopathy (DM).

View Article and Find Full Text PDF

Modeling stroke in animals is essential for testing efficacy of new treatments; however, previous neuroprotective therapies, based on systemic delivery in rodents failed, exposing the need for model with improved clinical relevance. The purpose of this study was to develop endovascular approach for inducing ischemia in swine. To achieve that goal, we used intra-arterial administration of thrombin mixed with gadolinium and visualized the occlusion with real-time MRI.

View Article and Find Full Text PDF

Adolescent idiopathic scoliosis (AIS) is a relatively frequent disease within a range 0.5%-5.0% of population, with higher frequency in females.

View Article and Find Full Text PDF
Article Synopsis
  • - The rising incidence of neurological disorders, due to longer life expectancies, calls for effective treatment strategies, with stem cell-based therapies seen as promising yet currently yielding disappointing clinical trial outcomes.
  • - Challenges such as poor cell survival and engraftment highlight the need for innovative solutions, and new advancements in biomaterials and bioprinting technology may offer a path to improved regenerative approaches for neurological conditions.
  • - Bioprinting allows for customizable scaffolds that aid in the integration of stem cells and can incorporate imaging capabilities for monitoring treatment effectiveness, making it a potentially valuable tool in developing better targeted therapies for conditions like stroke or traumatic brain injury.
View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive degeneration of motor neurons and grim prognosis. Over the last decade, studies on neurodegenerative diseases pointed on the role of glia in supporting the proper function of neurons. Particularly, oligodendrocytes were shown to be essential through myelin production and supplying axons with energy metabolites via monocarboxylate transporters (MCT).

View Article and Find Full Text PDF

Disseminated diseases of the central nervous system such as amyotrophic lateral sclerosis (ALS) require that therapeutic agents are delivered and distributed broadly. Intrathecal route is attractive in that respect, but to date there was no methodology available allowing for optimization of this technique to assure safety and efficacy in a clinically relevant setting. Here, we report on interventional, MRI-guided approach for delivery of hydrogel-embedded glial progenitor cells facilitating cell placement over extended surface of the spinal cord in pigs and in naturally occurring ALS-like disease in dogs.

View Article and Find Full Text PDF

Demyelinating disorders such as multiple sclerosis (MS) or transverse myelitis are devastating neurological conditions with no effective cure. Prevention of myelin loss or restoration of myelin are key for successful therapy. To investigate the disease and develop cures animal models with good clinical relevance are essential.

View Article and Find Full Text PDF

The prospects for cell replacement in spinal cord diseases are impeded by inefficient stem cell delivery. The deep location of the spinal cord and complex surgical access, as well as densely packed vital structures, question the feasibility of the widespread use of multiple spinal cord punctures to inject stem cells. Disorders characterized by disseminated pathology are particularly appealing for the distribution of cells globally throughout the spinal cord in a minimally invasive fashion.

View Article and Find Full Text PDF